Researchers report the first vaccine shown to protect nonhuman primates from melioidosis, a disease caused by Burkholderia pseudomallei. The findings appeared in a scientific journal and are described as a key step toward human clinical trials.
The bacteria live in soil and groundwater and can cause aggressive pneumonia or sepsis. The disease is thought to be underreported worldwide; estimates put the annual case count in the hundreds of thousands. Mortality is high partly because the bacteria resist many antibiotics and relapse can occur after treatment.
The vaccine uses outer membrane vesicles, nanoparticles from bacteria that trigger immune responses. Tests on human immune cell samples produced antibody and T cell responses, which suggest the vaccine could work in people. Development took more than a decade and involved international collaboration, and researchers say they aim to start human trials.
Difficult words
- melioidosis — Serious infectious disease caused by soil bacteria
- primate — Mammal like monkeys or apesnonhuman primates
- sepsis — Dangerous body-wide reaction to infection
- mortality — Number of deaths in a group
- antibiotic — Medicine that kills or stops bacteriaantibiotics
- vesicle — Small particle released from a bacterial cellouter membrane vesicles
- relapse — Return of a disease after treatment ends
Tip: hover, focus or tap highlighted words in the article to see quick definitions while you read or listen.
Discussion questions
- Why are human clinical trials the next important step after tests on nonhuman primates?
- How might antibiotic resistance affect treatment and prevention of this disease in your country?
- If a vaccine becomes available, what challenges could public health teams face to deliver it in areas with the bacteria?
Related articles
Damage to Iranian universities and research after airstrikes
Airstrikes have damaged many Iranian universities, campuses and laboratories. UNESCO and scientists warn that online classes cannot replace lab training and that the attacks could harm research and students' future careers.
Vitamin C may protect reproductive health from potassium perchlorate
A study using Japanese rice fish (medaka) found that potassium perchlorate damaged testes and reduced fertility. Fish given vitamin C alongside the chemical showed better fertility and less testicular harm, suggesting vitamin C may help protect reproductive health.
Certain infant formula fats linked to early liver fat
An animal study using newborn pigs found that formulas high in medium-chain fats from coconut oil led to faster liver fat accumulation than formulas with long-chain animal fats. Researchers say this finding is not a reason to stop using formula.